L B van de Putte is a scholar working on Rheumatology, Immunology and Genetics.
According to data from OpenAlex, L B van de Putte has authored 10 papers receiving a total of 956 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Rheumatology, 3 papers in Immunology and 2 papers in Genetics. Recurrent topics in L B van de Putte's work include Systemic Lupus Erythematosus Research (5 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and Chronic Lymphocytic Leukemia Research (2 papers). L B van de Putte is often cited by papers focused on Systemic Lupus Erythematosus Research (5 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and Chronic Lymphocytic Leukemia Research (2 papers). L B van de Putte collaborates with scholars based in Netherlands. L B van de Putte's co-authors include Désirée van der Heijde, P L van Riel, M. H. van Rijswijk, M. A. van Leeuwen, M B Pepys, P. C. Limburg, W.J. Sluiter, M. E. C. Jeurissen, P. J. S. M. Kerstens and Jules Fast and has published in prestigious journals such as The Lancet and PubMed.
In The Last Decade
L B van de Putte
9 papers
receiving
916 citations
Hit Papers
What are hit papers?
Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Countries citing papers authored by L B van de Putte
Since
Specialization
Citations
This map shows the geographic impact of L B van de Putte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L B van de Putte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L B van de Putte more than expected).
Fields of papers citing papers by L B van de Putte
This network shows the impact of papers produced by L B van de Putte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L B van de Putte. The network helps show where L B van de Putte may publish in the future.
Co-authorship network of co-authors of L B van de Putte
This figure shows the co-authorship network connecting the top 25 collaborators of L B van de Putte.
A scholar is included among the top collaborators of L B van de Putte based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with L B van de Putte. L B van de Putte is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
10 of 10 papers shown
1.
Vries, Niek de, Piet LCM van Riel, & L B van de Putte. (2002). Research in complex diseases. The Lancet. 359(9313). 1243–1245.1 indexed citations
2.
Kroot, E. J. A., et al.. (2001). Chronic comorbidity in patients with early rheumatoid arthritis: a descriptive study.. PubMed. 28(7). 1511–7.40 indexed citations
3.
Putte, L B van de, et al.. (1999). Hepatotoxicity of parenteral gold therapy in rheumatoid arthritis: a case report and review of the literature.. PubMed. 17(3). 359–62.5 indexed citations
4.
Leeuwen, M. A. van, M. H. van Rijswijk, W.J. Sluiter, et al.. (1997). Individual relationship between progression of radiological damage and the acute phase response in early rheumatoid arthritis. Towards development of a decision support system.. PubMed. 24(1). 20–7.165 indexed citations
5.
Hoogen, F.H.J. van den, A Schattenberg, F. C. Breedveld, Willem E. Fibbe, & L B van de Putte. (1997). [High-dose chemotherapy followed by hematopoietic stem cell transplantation as therapy for systemic rheumatic autoimmune diseases].. PubMed. 141(43). 2061–5.
6.
Putte, L B van de, et al.. (1997). Currently used second-line agents: do they control the disease course?. PubMed. 15 Suppl 17. S71–4.3 indexed citations
Jacobs, Marike J. M., et al.. (1993). Induction of tolerance by T-cell vaccination is possible beyond the area of autoimmunity: down-regulation of immunity directed to foreign protein antigens.. PubMed. 80(4). 511–7.5 indexed citations
9.
Kerstens, P. J. S. M., et al.. (1992). Accelerated nodulosis during low dose methotrexate therapy for rheumatoid arthritis. An analysis of ten cases.. PubMed. 19(6). 867–71.99 indexed citations
10.
Jeurissen, M. E. C., et al.. (1989). Methotrexate therapy in connective tissue diseases: a review of the literature.. PubMed. 35(1-2). 44–58.4 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.